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hardening is facilitated by mineral tubules 
becoming intermeshed, which ultimately 
causes the spheres to fuse. Formation 
of the calcium-loaded spheres and their 
capacity to fill an ex vivo defect in retrieved 
human bone is reported, in addition to the 
morphology, structure, and composition of 
the precipitated mineral phase.
A range of synthetic materials have been 
developed that are capable of filling hard 
tissue defects to overcome the issues that 
are often associated with autologous tissue 
harvesting, such as local tissue morbidity 
and lack of availability.[1,2] In particular, 
there have been many ceramic-based mate-
rials used for hard tissue augmentation. 
Calcium phosphate- and calcium sulfate-
based products are available commercially, 
but are yet to replace autograft as the so-
called “gold-standard.”[3,4] The ceramic 
materials used for the augmentation of 
hard tissues are often produced using 
high-temperature treatment processes, 
meaning that they are of high crystallinity and relatively low 
specific surface area.[5–7] Consequently, synthetic ceramic bone 
replacements often bear little resemblance to native bone min-
eral, which is predominantly nanocrystalline hydroxyapatite 
(HA, Ca5(PO4)3OH) that is poorly crystalline.[8] Even in the case 
of cements, which harden through reprecipitation in the body, 
much of the hardened structure is formed in the presence of 
excess microcrystalline reactant.[9,10] Moreover, many conven-
tional regenerative materials are absent of channels to support 
the penetration of surrounding vascular networks.[11,12] The 
level of structuring that is possible with synthetic alternatives 
to bone graft is limited to the production of biomimetic corals 
and sponge-like structures that provide an interporous network 
for bone regeneration, but replicate none of the microstructural 
organization of hard tissue at the osteonal level.[13–15] Hard tis-
sues exhibit precisely defined hierarchical architectures, with 
organization from the molecular level through to the macro-
scale. It is this well-preserved architecture that is critical to 
the extraordinary mechanical performance of bone, which is 
stronger and tougher per unit weight than steel.[13] Adopting 
bioinspired approaches to design biomaterials may further 
enable the generation of regenerative materials with advanced 
capabilities of function and cellular interaction.[16,17]
One preserved feature of hard tissue is the presence of intricate 
tubular networks, such as canaliculi, Haversian canals, and Volk-
mann’s canals found in mature bone, as well as dentinal tubules 
within teeth, that are critical to the function of such tissues.[18–20] 
A new bone augmenting material is reported, which is formed from calcium-
loaded hydrogel-based spheres. On immersion of these spheres in a physi-
ological medium, they become surrounded with a sheath of precipitate, which 
ruptures due to a build-up in osmotic pressure. This results in the formation of 
mineral tubes that protrude from the sphere surface. When brought into close 
contact with one another, these spheres become fused through the entangle-
ment and subsequent interstitial mineralization of the mineral tubules. The 
tubular calcium phosphate induces the expression of osteogenic genes (runt-
related transcription factor 2 (RUNX2), transcription factor SP7 (SP7), collagen 
type 1 alpha 1 (COL1A1), and bone gamma-carboxyglutamic acid-containing 
protein (BGLAP)) and promotes the formation of mineral nodules in preosteo-
blast cultures comparable to an apatitic calcium phosphate phase. Furthermore, 
alkaline phosphatase (ALP) is significantly upregulated in the presence of tubular 
materials after 10 d in culture compared with control groups (p < 0.001) and 
sintered apatite (p < 0.05). This is the first report of a bioceramic material that is 
formed in its entirety in situ and is therefore likely to provide a better proxy for 
biological mineral than other existing synthetic alternatives to bone grafts.
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Bone Regeneration
On immersion of calcium-containing hydrogel-based spheres in 
phosphate rich physiological media, a sheath of precipitate forms 
around the spheres, which ruptures due to an increase in osmotic 
pressure. This release of pressure drives the formation of bio-
logically analogous tubular mineral from the gel surface. When 
spheres are in close proximity to one another, a mechanism of 
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Tubular channels like these are essential for transporting chemi-
cals, gases, and nutrients in order to maintain the viability of cells 
cocooned within typically dense mineralized tissue. Mimicking 
the natural structural features of bone is a major challenge but 
one that is subject to substantial research effort. A prerequisite 
to facilitating the development of vascular networks throughout 
hard tissue scaffolds may be the provision of tubular structures 
similar in nature to those found in mineralized tissues. It has 
been shown that mineralized tubular frameworks provide an 
ideal framework to mediate revascularization of bone in vivo.[21]
Mineral tubes similar to those found in bone and teeth may 
be formed using a system that is analogous to a chemical garden, 
where hollow tubular precipitates form at the interface between 
a cationic seed crystal and an anionic solution.[22,23] These struc-
tures have been likened to a range of tubular minerals found 
throughout nature.[24,25] Surprisingly, there is relatively little 
work that examines the use of such systems for biotechnology 
applications despite the fact that tubes have been shown to sup-
port the entrapment and growth of cells.[26,27] With the exception 
of calcium silicates, phosphates, and carbonates, the majority 
of salts traditionally generated in chemical gardens would not 
be compatible with implantation into the body, including but 
not limited to cobalt, copper, iron, manganese, and nickel com-
pounds.[22–24,26,28] There has recently been work that has shown 
that it is possible to produce biologically relevant calcium 
phosphate structures at the interface between a cation-loaded 
hydrogel and anionic solution.[29–32] Indeed, we recently reported 
on the formation of tubular calcium phosphate that resembles 
tubular architectures found in bone both structurally and com-
positionally.[32] The generation of these structures results from 
the exposure of calcium-loaded agarose layered with a phosphate 
rich solution, which ultimately produces a forest of hollow white 
precipitate tubes (Figure 1a). Initially, a precipitate is formed at 
the gel–liquid interface, which impedes diffusion and creates an 
Adv. Healthcare Mater. 2018, 7, 1701166
Figure 1. a) Conventional experimental set-up we previously reported in ref. [32], which produces calcium phosphate tubules that are structurally and 
compositionally similar to microstructures within bone, providing the starting point for the work reported herein. b) Schematic of fabrication method of 
calcium-loaded spheres, involving drop-wise addition of calcium-loaded agarose hydrogel into a reservoir of liquid nitrogen. c) Calcium-loaded spheres 
before and after mineralization, showing the ejection of tubular calcium phosphate mineral. d) SEM micrograph showing the tubule microstructure, 
consisting of a bilayer tubule wall surrounding a hollow core. e) SEM micrograph of tube wall bilayer structuring. f) µ-XRF elemental mapping of a 
calcium phosphate tubule cross section (Kα channels for calcium (red) and phosphorous (green) shown).
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osmotic pressure. When the osmotic pressure causes localized 
rupture of the precipitate layer, calcium ions are able to diffuse 
into the liquid phase where a tubular calcium phosphate-based 
precipitate forms.[32,33] Growth of these tubes is maintained 
through cyclic build-ups in osmotic pressure and release, which 
drives calcium ions through the established tubule to the tip 
where it ruptures, and a new section of tubule is formed.[32,33] 
The mineral from which these tubules are formed is of low crys-
tallinity calcium phosphate, similar to that found in the body.
The tubular precipitate did not only form on planar surfaces, 
but also formed when spheres of hydrogel prepared with a 1 m  
calcium nitrate solution were placed into a 0.5 m phosphate-
augmented physiological solution. The spheres were produced 
through the drop-wise addition of hot (80–90 °C) calcium-loaded 
agarose gel mixture through a 2 mm wide pipette aperture 
into a reservoir of liquid nitrogen (Figure 1b). Upon contact 
with the liquid nitrogen, the gel droplets quickly solidify as 
spheres through the inverse Leidenfrost effect.[34] The resulting 
particles were of average diameter 3.7 ± 0.4 mm (mean of 
n = 10 ± standard deviation (SD)). The use of this method of 
manufacture meant that we were able to produce spherical aga-
rose particles that were loaded with relatively high concentrations 
of calcium ions (>1 m), which would be very difficult to achieve 
using standard processing methods or if soaking preformed 
spheres in cation-containing solutions.[35] Agarose was selected 
as the soft material of choice as a consequence of its neutral 
charge, meaning that it does not impede diffusion of the cal-
cium ions. Others have reported the use of mineralized hydrogel, 
including agarose-based systems, for bone augmentation.[36–40] 
The novelty of the system described in this paper is the ability 
to generate biologically analogous calcium phosphate structures 
that aid in hardening an osteogenic bone graft material in situ.
When the calcium-loaded spheres were immersed in phos-
phate solutions, tubules precipitated around the periphery of 
the particles but grow preferentially upward due to buoyancy 
effects (Figure 1c).[23] Altering the metal and reactive counter 
ion concentrations directly influences the kinetic driving forces 
of tubular self-assembly, including osmotic, diffusion, and pH 
gradients that exist within the material system. This influences 
the gross morphology of the tubes and can also be used to 
adjust formation rate. Increasing phosphate solution concen-
tration from 500 × 10−3 m to 1 m allows control over mineral 
tubular growth rate between 0.3 mm min−1 (18 mm h−1) to 
0.5 mm min−1 (30 mm h−1) (Figure S1, Supporting Information).
Scanning electron microscopy (SEM) images show that the 
tubules typically exhibit diameters between 100 and 150 µm, 
which is ideal for ingress of osteogenic cells (Figure 1d).[41] 
Additionally, these channels facilitate mass transport of ionic 
solute during structure formation, similar to how osteon 
structures direct the flow of blood within Haversian systems 
in order to exchange nutrients and gases. They also exhibit a 
hierarchical bilayer wall structure comprised of low crystal-
linity HA (Ca5(PO4)3OH) and dicalcium phosphate dihydrate 
(CaHPO4·2H2O) (Figure 1e; Figure S2, Supporting Informa-
tion). This structure develops inwards as a consequence of 
the contrasting environments inside and outside of the tube 
resulting in a steep concentration gradient of reactive species 
across the tube wall. This ultimately results in a calcium rich 
inner wall and phosphate rich outer wall (Figure 1f).[42]
Mineralizing calcium-loaded spheres placed in close con-
tact with one another fuse through the formation of precipitate 
and the development of interweaving tubes at their periphery 
(Figure 2a). The interactions formed between the spheres 
were of sufficient strength to allow for the fusion of multiple 
spheres to form a larger structure (Movie S1, Supporting Infor-
mation). Elemental mapping using micro X-ray fluorescence 
(µ-XRF) confirmed that the particles were united by a calcium 
phosphate phase (Figure 2b). It was possible to assemble the 
gel spheres into relatively complex geometries, such as the 
pyramid shown in Figure 2c. 3D microcomputed tomography 
(µ-CT) reconstructions of this structure show that mineral cov-
erage (red and green) occurs extensively across the surfaces of 
hydrogel spheres (blue), and even in the center of the structure 
(Figure 2d). Mechanical properties of hardened cylindrical struc-
tures (12 mm high by 12 mm wide) were assessed under com-
pressive loading to ascertain the adhesion between the spheres 
of a mineralized construct. Structures possessed a compressive 
strength of 200 ± 40 kPa (mean of n = 3 ± SD). Although the 
interfacial precipitate that develops between spheres is able to 
support the formation of mineralized constructs, subsequent 
failure of these structures under relatively low forces suggests 
application in the treatment of low-load bearing defects, such as 
that of the craniofacial skeleton. Despite the low resistance of 
mineralized spheres to load, within an augmented defect space 
the integrity of a hardened network of spheres will likely be 
supported by adjacent hard tissue. Furthermore, the strength 
of the graft may be improved over time by the ingress of newly 
forming bone between spherical structures and the integration 
of tubules with native bone interfaces.
To demonstrate that this approach could be used for the aug-
mentation of a hard tissue defect, a cylindrical defect ≈10 mm 
wide and 15 mm deep was introduced into an ex vivo human 
tissue sample, which was then packed with calcium-loaded 
spheres (Figure 3a). The filled defect was then placed into a 
phosphate rich medium (1 m phosphate solution), and mineral 
was observed to form rapidly across the surface with the for-
mation of tubes becoming apparent soon thereafter. After 24 h, 
this structure could be inverted and irrigated with water without 
a loss of mechanical integrity (Movie S2, Supporting Informa-
tion). µ-CT revealed the extent of mineral deposition within the 
defect (Figure 3b). Cross-sectional images show mineral around 
the surface of spheres and tubular structures within the defect, 
filling the interparticulate spaces with a mineral phase. From 
µ-CT examination, the interfaces between the spheres and the 
mineral deposited are extremely difficult to differentiate from 
the opposing bone. µ-XRF analysis demonstrates that the ele-
mental composition of precipitated calcium phosphate mineral 
is similar to the surrounding tissue, also making it difficult to 
distinguish a clear interface between bone and the spheres. It 
is likely that compositional similarities between mineral phases 
aid the bone bonding capability of the system at the interface 
between bone tissue and mineral releasing spheres (Figure 3c; 
Figure S3, Supporting Information).
In order to demonstrate the biocompatibility of tubular pre-
cipitate and assess its osteoinductive properties, we analyzed its 
capacity to induce osteogenesis within a population of murine 
MC3T3 preosteoblasts. Our findings were compared with a 
synthetic HA phase that had undergone a sintering treatment 
Adv. Healthcare Mater. 2018, 7, 1701166
www.advancedsciencenews.com www.advhealthmat.de
1701166 (4 of 9) © 2019 University of Birmingham. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
(HA). Similar phases are routinely applied as bone grafts, and 
therefore provided an osteogenic control within this study.[5–7]
The biological response of MC3T3 cells to tubular mineral 
was examined using a transwell culture system in which our 
calcium phosphate tubes were distributed within an insert 
chamber, and the indirect effects were monitored. Cell viability 
assessed using calcein AM/propidium iodide staining demon-
strated that tubular mineral exhibited no adverse cytotoxic 
effects over a period of 10 d (Figure 4a). This was further con-
firmed by alamar blue, which overall identified comparable 
levels of metabolic activity in line with both positive and nega-
tive controls, as well as the HA standard (Figure 4b).
In order to examine the comparative osteoinductive effects of 
tubes, we analyzed levels of alkaline phosphatase (ALP) activity 
in each culture at 3, 7, and 10 d time points (Figure 4c). Levels 
of ALP generally increased for all treatments over a period 
of 10 d in culture. At day 3, ALP generated by cells in pro-
osteogenic media and HA groups was significantly increased 
(p < 0.001) compared with negative control and Tube groups, 
albeit at relatively low levels. ALP was found to be significantly 
(p < 0.001) upregulated in the positive osteogenic control at 
day 7 when compared with both HA and Tube groups, which 
is likely related to the availability of free phosphates (exog-
enous β-glycerophosphate) for cells to utilize within these 
Adv. Healthcare Mater. 2018, 7, 1701166
Figure 2. a) Fusion of two calcium-loaded spheres in close proximity to one another during mineralization. b) µ-XRF elemental mapping of a 
calcium-loaded sphere cross-section before and after inducing mineralization (Kα channels for calcium (red) and phosphorous (green) shown). 
c) Calcium-loaded sphere pyramid construct before and after triggering mineralization, leading to complete unification. d) µ-CT of calcium-loaded 
sphere pyramid after submersion in phosphate solution. Color scales in-set represent an increase in relative density of material from blue (calcium-
loaded sphere) to green and red (mineral).
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particular control groups. However, by day 10, ALP activity was 
significantly upregulated in the Tube group compared with 
the negative control (p < 0.001), positive control (p < 0.001), 
and sintered HA groups (p < 0.05). Detection of significantly 
enhanced levels of ALP in the Tube groups suggests that even 
in an early stage of in vitro culture, tubular calcium phosphate 
is able to facilitate favorable conditions for osteogenic differen-
tiation more so than synthetic HA.
The relative osteoinductive effects of tubular mineral were 
further determined using quantitative real-time polymerase 
Adv. Healthcare Mater. 2018, 7, 1701166
Figure 3. a) Schematic of calcium-loaded spheres augmenting an ex vivo human bone defect, showing an empty bone defect, the packing of spheres 
to augment the defect, and triggering of mineralization with 1 m phosphate solution. b) µ-CT of human hard tissue model containing mineralized 
calcium-loaded spheres that have deposited mineral and tubular structures within the defect. c) µ-XRF elemental mapping of a cross-section of the 
human hard tissue defect (Kα channels for calcium (red) and phosphate (green) shown).
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chain reaction (qRT-PCR) to reveal the expression of genetic 
markers for both immature and mature osteoblasts (Figure 4d). 
The expression of early osteogenic markers runt-related tran-
scription factor 2 (RUNX2) and transcription factor SP7 (SP7) 
were in line with the osteogenic control. RUNX2 and SP7 were 
significantly reduced in the Tube group at day 3 when compared 
with HA (p = 0.033; p = 0.024, respectively), possibly indicating 
an earlier primary osteogenic response in this culture. The 
expression of collagen type 1 alpha 1 (COL1A1) was upregulated 
in all treatments compared with the negative control but not 
significant between treatments, which indicates that the rate of 
extracellular matrix (ECM) deposition is not negatively affected 
following exposure to calcium phosphate tubes. Similarly, 
expression of the mature osteoblast marker bone gamma-car-
boxyglutamic acid-containing protein (BGLAP) are comparable 
between preosteoblasts exposed to tubular precipitate, HA and 
the osteogenic control over a period of 10 d in culture.
Formation of comparable calcified nodules was observed at 
day 10 in all cultures, as shown by alizarin red staining. Nod-
ules formed in the presence of tubes were comparable to those 
observed in the presence of HA (Figure 4e). Collectively, these 
results demonstrate that tubular calcium phosphate mineral 
generated by calcium-loaded hydrogel spheres in the present 
study is biocompatible and exhibits an osteoinductive profile 
consistent with a clinically applied calcium phosphate, such as 
sintered HA. Further work will need to be conducted to deter-
mine the osteoconductive topographic effects of the tubular 
structures to comprehensively define its efficacy as a scaffold 
for hard tissue repair.
Inspired by processes that are able to mimic the generation of 
natural tubular mineral structures, we have developed a device 
capable of augmenting a hard tissue defect through the produc-
tion of tubular mineral. The material consists of calcium-loaded 
spheres manufactured using a process that allows for the incor-
poration of high concentrations of calcium. Immersion of 
these spheres in physiologically relevant solutions rich in phos-
phate stimulates tube formation, which means that they could 
be ideal for use in biological environments. Compared with the 
majority of synthetic bone substitutes that are typically dense 
and highly crystalline, this system enables (1) the formation 
of tubular calcium phosphate mineral that is structurally and 
compositionally akin to the tubular features found in bone and 
tooth, providing a structured osteogenic scaffold, (2) mineral 
formation in situ in the absence of microcrystalline reactant, 
facilitating a low crystallinity product comparable to the sur-
rounding hard tissue, and (3) tunable mineral synthesis by the 
adjustment of precipitation parameters, enabling physical prop-
erties such as fusion time to be modified using physiologically 
relevant conditions, such as phosphate solution concentrations. 
The microscale structural features of the mineral phase may 
also enable better vascularization of the implant.[21]
In summary, we present a strategy for directly delivering 
hierarchical tubular mineral into hard tissue defects using 
spheres of agarose hydrogel loaded with calcium. In phos-
phate solutions, these spherical structures fuse, forming a solid 
through the intermeshing of mineral tubules that are expelled 
from the surface of the soft material.
Experimental Section
Calcium-Loaded Hydrogel Fabrication and Mineral Initiation: Calcium-
loaded gels were made by adding 5 wt% agar powder (for microbiology, 
Sigma-Aldrich, UK) to 1 m calcium solutions prepared from calcium 
nitrate tetrahydrate crystals (99%, ACS reagent, Sigma-Aldrich, UK) and 
distilled water before heating the mixture to 80–90 °C. For conventional 
set-up, a layer of gel was set in clear cylindrical containers and allowed 
to cool to room temperature. For calcium-loaded spheres, warm gel was 
added drop-wise to an insulated chamber of liquid nitrogen. Spheres 
were collected after dissipation of the nitrogen. Mineralization was 
initiated upon gel surfaces, calcium-loaded sphere constructs, and within 
an ex vivo bone defect using phosphate solutions prepared by dissolving 
crystals of dibasic ammonium phosphate (≥98.0%, reagent grade, 
Sigma-Aldrich, UK) at concentrations between 500 × 10−3 m and 1 m.
Compressive Strength Testing of Mineralized Constructs: Calcium-
loaded hydrogel spheres containing 1 m calcium ions were packed into 
a 12 × 12 mm cylinders. Mineralization was initiated by submerging 
the constructs in 1 m dibasic ammonium phosphate solution, and 
the hardened structures were recovered after 24 h. Mechanical data 
was collected using a Zwick/Roell Z030 universal tester equipped 
with a 100 N load cell. Compression tests were performed at a speed 
of 1 mm min−1, until failure of the specimens. The maximum force to 
failure was noted and used to calculate the compressive strength with 
Equation (1)
/F Aσ =  (1)
where σ is compressive strength (MPa), F is force (N), and A is contact 
area (mm2).
Units of compressive strength were subsequently converted from 
MPa to kPa thereafter.
SEM: Samples were placed on an aluminum stub using double-
sided sticky carbon discs. Gold sputter coating was performed prior 
to imaging using a K550X sputter coater (Quorum Technologies, UK). 
SEM images were then acquired using an EVO MA 10 scanning electron 
microscope (Carl Zeiss AG, Germany).
µ-XRF: Specimens were elementally mapped using an M4 Tornado 
instrument (Bruker, USA). Measurement settings of 20 ms pixel−1 over 
25 frames in the case of Figures 1f and 2 frames in the case of Figures 2b 
and 3C, were employed with the instrument operating at 50 kV with 
anode current of 300 mA. During measurements, the chamber was 
maintained at 500 mbar in case of Figure 1f.
Human Tissue Model: Bone tissue was collected from patients 
undergoing elective knee replacement surgery. The United Kingdom 
Figure 4. a) Fluorescent microscope images of cells stained with calcein AM and propidium iodide, showing viable cells (green) and dead cells 
(red). MC3T3 cells were cultured either in supplemented media (negative control group = −ve) or supplemented osteogenic media (positive con-
trol group = +ve), and additionally in supplemented media in the presence of synthetic HA that had been sintered (HA), as well as tubular calcium 
phosphate (Tubes). For reference, these groups correspond to the remaining parts of this figure as indicated. b) Metabolic activity of MC3T3 cells as 
determined by alamar blue (mean of n = 6 ± SD). c) Detection of ALP produced by MC3T3 cells (mean of n = 3 ± SD). d) Corresponding gene expres-
sion of RUNX2, SP7, COL1A1, and BGLAP determined by qRT-PCR (mean of n = 3 ± SD). For panels (b–d), significant difference found by one-way 
ANOVA and post-hoc statistical testing analysis is indicated by *, **, and ***, which correspond to p values of p < 0.05, p < 0.01, and p < 0.001, 
respectively. e) Optical microscopy of cultures fixed and stained with alizarin red showing the formation of comparable mineral nodules in the presence 
of osteogenic media, HA and Tube groups after 10 d.
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National Research Ethics Service (East of Scotland Research Ethics 
Service) provided ethical approval (11/ES/1044). Tissues were washed 
using phosphate buffered saline (PBS) (calcium and magnesium free, 
Sigma-Aldrich, UK) before defects 10 mm wide and a minimum of 
10 mm deep were introduced using a surgical drill. Calcium-loaded 
spheres were gently packed into defect spaces and mineralization 
initiated as detailed above.
CT Scanning: Samples were transferred to a sealed low X-ray 
attenuation tube. Structures were scanned using a Skyscan1172 µ-CT 
instrument (Bruker, USA) with 60 kV maximum X-ray energy, 6 W beam 
power, 2000 ms exposure per projection, and 12.44 µm pixel size. 
Slice data was reconstructed using NRecon (Version 1.6.10, Bruker) 
and visualized using CTVox (Version 3.0, Bruker). For mineralizing 
sphere pyramid constructs, grayscale images were artificially colored 
by assigning blue, green, and red transfer functions to grayscale ranges 
matching the calcium-loaded spheres (blue) and mineralized regions 
(green and red). For the mineralized human defect model, an opacity 
transfer function was applied to best segment the grayscale range 
corresponding to the tubules from the rest of the structure to render 3D 
images of deposited mineral within the defect.
Synthesis of Synthetic Hydroxyapatite and Sintering Procedure: HA 
was prepared by sol–gel precipitation following a reported method.[43] 
For sintering, powder was transferred to a heatproof ceramic dish and 
subjected to 650 °C for 3 h in a CWF 1300 furnace (Carbolite, UK). The 
heating and cooling ramp rate was set at 5 °C min−1, and sintered HA 
powder (HA) was recovered only after the furnace had returned to room 
temperature.
In Vitro Cell Culture: MC3T3 murine preosteoblast cells were 
purchased from America Type Culture Collection (ATCC) and used 
between passages 4 and 6. Cells were initially cultured in growth 
medium consisting of alpha-modified Minimum Essential Medium 
supplemented with 10% fetal bovine serum (FBS), 2.4% l-glutamine, 
and 1% penicillin/streptomycin. Osteogenic medium was further 
supplemented with 10 × 10−3 m β-glycerophosphate, 50 µg mL−1 
l-ascorbic acid, and 10 × 10−9 m dexamethasone (Sigma-Aldrich, UK).
Cell Viability: Viability was assessed at days 3 and 10. Cell cultures 
were immersed in 1 mL growth medium supplemented with 
3 × 10−6 m calcein acetoxymethyl ester (Calcein AM, Life Technologies, 
UK) and 1 × 10−6 m propidium iodide (Life Technologies, UK) and 
incubated at 37 °C for 5 min. Cell viability was determined visually using 
an Olympus IX81 fluorescence microscopy (Olympus, USA).
Alamar Blue Metabolic Activity: MC3T3s were seeded at a density of 
6.5 × 103 cells cm−2 in growth medium and allowed to adhere at 37 °C 
for a period of 24 h. Following 24 h culture transwell inserts (0.4 µm 
ThinCert, Greiner Bio-One, Austria) containing 20 mg sintered HA 
or 20 mg tubular precipitate (Tubes) were incorporated and the total 
media volume adjusted to 2 mL. Metabolic activity was assessed 
at every 24 h over a total period of 5 d by incorporating 10% Alamar 
Blue reagent (Life Technologies, UK) into the cell culture medium and 
measuring absorbance at 570 nm using a Synergy HT microplate reader 
(Biotek, UK).
ALP Activity: Cellular ALP activity was quantified using the SensoLyte 
pNPP ALP Assay Kit (AnaSpec, USA). MC3T3s were plated in 12-well 
plates at an initial seeding density of 26 × 103 cells cm−2 in the presence 
of 1 mL growth medium. Following 24 h culture transwell inserts (0.4 µm 
ThinCert, Greiner Bio-One, Austria) containing 20 mg sintered HA or 
20 mg tubular HA (Tubes) were incorporated and the total media volume 
adjusted to 2 mL. ALP activity was measured at 3, 7, and 10 d according 
to the manufacturer’s instructions. Briefly, cell monolayers were washed 
twice using 1× assay buffer provided. Cells were detached from the 
surface of the culture plate in the presence of 200 µL permeabilization 
buffer using a cell scraper. The resulting cell suspension was collected 
in a microcentrifuge tube, incubated at 4 °C for 10 min under agitation, 
and then centrifuged at 2500 g for 10 min. Supernatant was transferred 
to a 96-well plate where it was combined with an equal volume of pNPP 
substrate. Absorbance was measured at 405 nm using a Synergy HT 
microplate reader (Biotek, UK). ALP activity was normalized to DNA 
concentration (see the “DNA isolation” section).
RNA Isolation and qRT-PCR: Following culture, total RNA was isolated 
using TRIzol reagent (LifeTechnologies, UK); the manufacturer’s 
instructions were followed. Briefly, TRIzol reagent was used to directly 
lyse cells before chloroform (Sigma Aldrich, UK) was added to separate 
the aqueous RNA phase through centrifugation. The RNA phase was 
removed and isopropanol (Fisher Scientific, UK) was added to precipitate 
the RNA. The precipitate was centrifuged and then washed with 75% 
ethanol prepared from absolute (Fisher Scientific, UK) before drying in 
a vacuum desiccator. Finally, the pellet was resuspended in molecular 
biology grade water (Fisher Scientific, UK). RNA concentration and 
A260/280 ratio were measured using a spectrophotometer (NanoDrop 
2000, ThermoScientific).
QuantiFast one-step master mix (Qiagen) was used to measure 
mRNA expression of RUNX2, SP7, COL1A1, BGLAP, and β-actin, 
which was used as a housekeeping gene. All primer sequences were 
designed by KiCqStart and supplied by Sigma-Aldrich (Gillingham, UK); 
forward and reverse sequences are shown in Table S1 in the Supporting 
Information. qRT-PCR was performed using a BioRad CFX384 (BioRad, 
USA), and relative expression was calculated using ddCT, normalized to 
β-actin.
DNA Isolation: DNA was purified from interphase and organic phase 
components collected during RNA isolation following removal of the 
RNA phase (see RNA Isolation and qRT-PCR of methods section). Briefly, 
absolute ethanol was added to the mixtures, which were incubated for 
3 min, before centrifugation to pellet the DNA. DNA was washed twice 
by resuspending the pellet in 0.1 m sodium citrate (Sigma Aldrich, UK) 
solution prepared with 90% molecular grade water and 10% ethanol, 
incubating for 30 min, and centrifugation at 2000 × g for 5 min at 4 °C. 
DNA was then resuspended in a 75% ethanol and 25% molecular water 
solution, incubated for 20 min before being centrifuged, and the pellet air 
dried for 10 min following removal of the supernatant. Finally, the pellet 
was resuspended in 8 × 10−3 m NaOH solution prepared with molecular 
grade water, and the DNA concentration and A260/280 ratio measured 
using a spectrophotometer (NanoDrop 2000, ThermoScientific). ALP 
activity was normalized to the DNA concentration.
Alizarin Red Calcium Staining: Cultures were washed using sterile PBS 
and subsequently fixed with 4% paraformaldehyde for 20 min at room 
temperature. 40 × 10−9 m alizarin red solution (Sigma-Aldrich, UK), 
which had been adjusted to pH 4.2 using ammonium hydroxide was 
applied to each culture for a period of 20 min. Unbound stain was eluted 
by successive washes in PBS. Images were captured using an INVERSO 
TC100 inverted microscope (Resolution, UK) at 10× magnification.
Statistical Analysis: All statistically analysis was performed using 
SigmaPlot 13.0 software. All groups underwent normality testing by 
Shapiro–Wilk method and equal variance testing by Brown–Forsythe 
method. One-way analysis of variance (ANOVA) was used to determine 
if statistical differences existed between sample groups at different 
time points, with alpha level of 0.05. Post-hoc all pairwise multiple 
comparison tests were performed using the Holm–Sidak method. 
Values of p < 0.05 were deemed to be significant.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
Acknowledgements
All authors contributed equally to this work. E.H., R.W., and L.G. 
developed the device concept discussed herein. E.H. and T.H. fabricated 
calcium-loaded spheres using liquid nitrogen method described. E.H., 
M.C., and L.G. developed the ex vivo human bone defect model. E.H. 
and S.C. performed µ-CT scanning. E.H. and O.D. undertook in vitro 
biological experiments. E.H., O.D., and M.C. performed qRT-PCR 
analysis. The authors thank the financial support provided by the EPSRC 
www.advancedsciencenews.com www.advhealthmat.de
1701166 (9 of 9) © 2019 University of Birmingham. Published by Wiley-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Healthcare Mater. 2018, 7, 1701166
(project number 1294393 – medical materials) undertaken in association 
with TWI Ltd.
Conflict of Interest
The authors declare no conflict of interest.
Keywords
bone augmentation, hard tissue defect model, mineralization, tubular 
mineral
Received: October 2, 2017
Revised: November 8, 2017
Published online: January 11, 2018
[1] R. F. LaPrade, J. C. Botker, Arthroscopy 2004, 20, e69.
[2] G. M. Calori, M. Colombo, E. L. Mazza, S. Mazzola, E. Malagoli, 
G. V. Mineo, Injury 2014, 45, 116.
[3] S. V. Dorozhkin, Ceram. Int. 2015, 41, 13913.
[4] H. Shegarfi, O. Reikeras, J. Orthop. Surg. 2009, 17, 206.
[5] A. B. Hazar Yoruç, A. Karakas¸, A. Koyun, T. Yildiz, Acta Phys. Pol., A 
2012, 121, 233.
[6] A. L. Giraldo-Betancur, D. G. Espinosa-Arbelaez, A. d. Real-López, 
B. M. Millan-Malo, E. M. Rivera-Muñoz, E. Gutierrez-Cortez, 
P. Pineda-Gomez, S. Jimenez-Sandoval, M. E. Rodriguez-García, 
Curr. Appl. Phys. 2013, 13, 1383.
[7] M. Prakasam, J. Locs, K. Salma-Ancane, D. Loca, A. Largeteau, 
L. Berzina-Cimdina, J. Funct. Biomater. 2015, 6, 1099.
[8] W. Querido, A. L. Rossi, A. P. C. Campos, A. M. Rossi, M. Farina, 
Mater. Res. 2013, 16, 970.
[9] T. J. Brunner, R. N. Grass, M. Bohner, W. J. Stark, J. Mater. Chem. 
2007, 17, 4072.
[10] L. C. Chow, Dent. Mater. J. 2009, 28, 1.
[11] M. Lovett, K. Lee, A. Edwards, D. L. Kaplan, Tissue Eng., Part B 
2009, 15, 353.
[12] L. H. Nguyen, N. Annabi, M. Nikkhah, H. Bae, L. Binan, S. Park, 
Y. Kang, Y. Yang, A. Khademhosseini, Tissue Eng., Part B 2012, 18, 363.
[13] U. G. K. Wegst, H. Bai, E. Saiz, A. P. Tomsia, R. O. Ritchie, Nat. 
Mater. 2014, 14, 23.
[14] D. W. Green, W. F. Lai, H. S. Jung, Mar. Drugs 2014, 12, 2877.
[15] D. W. Green, B. Ben-Nissan, K. S. Yoon, B. Milthorpe, H. S. Jung, 
Trends Biotechnol. 2017, 35, 43.
[16] P. Yu, C. Ning, Y. Zhang, G. Tan, Z. Lin, S. Liu, X. Wang, H. Yang, 
K. Li, X. Yi, Y. Zhu, C. Mao, Theranostics 2017, 7, 3387.
[17] M. Yang, Y. Shuai, C. Zhang, Y. Chen, L. Zhu, C. Mao, H. OuYang, 
Biomacromolecules 2014, 15, 1185.
[18] D. M. Cooper, C. D. Thomas, J. G. Clement, A. L. Turinsky, 
C. W. Sensen, B. Hallgrimsson, Bone 2007, 40, 957.
[19] I. S. Maggiano, C. M. Maggiano, J. G. Clement, C. D. L. Thomas, 
Y. Carter, D. M. L. Cooper, J. Anat. 2016, 228, 719.
[20] J. Jowsey, J. Anat. 1966, 100, 857.
[21] S. Krauss, W. Wagermaier, J. A. Estevez, J. D. Currey, P. Fratzl, 
J. Struct. Biol. 2011, 175, 457.
[22] R. D. Coatman, N. L. Thomas, D. D. Double, J. Mater. Sci. 1980, 15, 
2017.
[23] J. H. Cartwright, B. Escribano, C. I. Sainz-Daz, Langmuir 2011, 27, 
3286.
[24] L. M. Barge, S. S. Cardoso, J. H. Cartwright, G. J. Cooper, L. Cronin, 
A. De Wit, I. J. Doloboff, B. Escribano, R. E. Goldstein, F. Haudin, 
D. E. Jones, A. L. Mackay, J. Maselko, J. J. Pagano, J. Pantaleone, 
M. J. Russell, C. I. Sainz-Diaz, O. Steinbock, D. A. Stone, 
Y. Tanimoto, N. L. Thomas, Chem. Rev. 2015, 115, 8652.
[25] S. S. Cardoso, J. H. Cartwright, A. G. Checa, C. I. Sainz-Díaz, Acta 
Biomater. 2016, 43, 338.
[26] K. Punia, M. Bucaro, A. Mancuso, C. Cuttitta, A. Marsillo, A. Bykov, 
W. L’Amoreaux, K. S. Raja, Langmuir 2016, 32, 8748.
[27] B. C. Batista, P. Cruz, O. Steinbock, ChemPhysChem 2015, 16, 2299.
[28] L. M. Barge, I. J. Doloboff, L. M. White, G. D. Stucky, M. J. Russell, 
I. Kanik, Langmuir 2012, 28, 3714.
[29] K. Kamiya, T. Yoko, K. Tanaka, Y. Fujiyama, J. Mater. Sci. 1989, 24, 
827.
[30] M. Tanahashi, K. Kamiya, T. Suzuki, H. Nasu, J. Mater. Sci.: Mater. 
Med. 1992, 3, 48.
[31] C. J. Steenbjerg Ibsen, B. F. Mikladal, U. Bjornholt Jensen, 
H. Birkedal, Chem. Eur. J. 2014, 20, 16112.
[32] E. A. Hughes, R. L. Williams, S. C. Cox, L. M. Grover, Langmuir 
2017, 33, 2059.
[33] J. H. Cartwright, J. M. Garcia-Ruiz, M. L. Novella, F. Otalora, J. Col-
loid Interface Sci. 2002, 256, 351.
[34] M. Adda-Bedia, S. Kumar, F. Lechenault, S. Moulinet, M. Schillaci, 
D. Vella, Langmuir 2016, 32, 4179.
[35] R. Makki, M. Al-Humiari, S. Dutta, O. Steinbock, Angew. Chem., Int. 
Ed. 2009, 48, 8752.
[36] G. Tozzi, A. De Mori, A. Oliveira, M. Roldo, Materials 2016, 9, 267.
[37] Z. Li, Y. Su, B. Xie, H. Wang, T. Wen, C. He, H. Shen, D. Wu, 
D. Wang, J. Mater. Chem. B 2013, 1, 1755.
[38] A. Han, G. Rujijanagul, C. Randorn, Mater. Lett. 2017, 193, 142.
[39] J. Watanabe, M. Kashii, M. Hirao, K. Oka, K. Sugamoto, 
H. Yoshikawa, M. Akashi, J. Biomed. Mater Res., Part A 2007, 83, 
845.
[40] J. Hu, Y. Zhu, H. Tong, X. Shen, L. Chen, J. Ran, Int. J. Biol. 
Macromol. 2016, 82, 134.
[41] L. Cerroni, R. Filocamo, M. Fabbri, C. Piconi, S. Caropreso, 
S. G. Condò, Biomol. Eng. 2002, 19, 119.
[42] L. Roszol, O. Steinbock, Phys. Chem. Chem. Phys. 2011, 13, 20100.
[43] I. Mobasherpour, M. S. Heshajin, A. Kazemzadeh, M. Zakeri, 
J. Alloys Compd. 2007, 430, 330.
